- Companies
- Aedes
Aedes Valuation Multiples
Aedes is valued at $12M as of October 2026, a 14.1x revenue multiple. In the last fiscal year, Aedes revenue was $1M and Aedes EBITDA was ($979K).
Aedes Overview
About Aedes
Aedes SIIQ is an Italian real estate investment company based in Milan that owns, manages and develops property. It was set up as a listed real estate investment trust and holds commercial and residential assets in Italy. The company is controlled by Domus, a vehicle backed by Hines, funds managed by affiliates of Apollo and the Italian investor VI-BA, which bought 54.86 percent of the share capital in December 2022 and then made a mandatory tender offer at 0.2922 euro per share. In 2026 it bought a residential property in Courmayeur for 1.55 million euros through a newly formed wholly owned subsidiary, Immobiliare Langhe, planning to renovate and resell the units. Its subsidiary Lavip has also bought commercial property. The company reported a return to positive EBITDA in the first half of 2026, driven by lease income and sales of property inventory.
Founded
1905
HQ
Employees
55
Website
Financials (Last FY)
EV
$15M
Valuation Multiples
Start free trialAedes Financials
Aedes reported last fiscal year revenue of $1M and negative EBITDA of ($979K).
In the same fiscal year, Aedes generated $499K in gross profit, ($979K) in EBITDA losses, and $297K in net income.
Aedes P&L
In the most recent fiscal year, Aedes reported revenue of $1M and EBITDA of ($979K).
Aedes is profitable as of last fiscal year, with gross margin of 48%, EBITDA margin of (94%), and net margin of 28%.
Financial data powered by Morningstar, Inc.
Aedes Stock Performance
Aedes has current market cap of $12M, and enterprise value of $15M.
Market Cap Evolution
Aedes' stock price is $0.94.
Aedes has an EPS (earnings per share) of $0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15M | $12M | 0.0% | - | - | - | $0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAedes Valuation Multiples
Aedes trades at 14.1x EV/Revenue multiple, and (15.1x) EV/EBITDA.
Aedes Financial Valuation Multiples
As of October 20, 2026, Aedes has market cap of $12M and EV of $15M.
Aedes has a P/E ratio of 40.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Aedes Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Aedes Margins & Growth Rates
In the most recent fiscal year, Aedes reported gross margin of 48%, EBITDA margin of (94%), and net margin of 28%.
Aedes Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Aedes Operational KPIs
Aedes' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Aedes Competitors
Aedes competitors include Gafisa, Fastator, Tecnisa, TMM Real Estate, RomReal, Multihome, Aquaticus Real Estate, Torre Almirante FII, BBI Development and Joao Fortes Engenharia.
Most Aedes public comparables operate across Buildings & Property and Real Estate Development.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $122M | ($85M) | 2.7x | - | (3.8x) | - | |||
| $22M | ($38M) | 2.5x | 2.3x | (1.5x) | - | |||
| $40M | ($4M) | 1.7x | - | (15.7x) | - | |||
| $19M | $2M | 0.6x | - | 5.2x | - | |||
| $3M | $2M | 1.8x | - | 2.7x | - | |||
| $2M | $56K | 6.8x | - | 227.0x | - | |||
| $5M | $3M | 9.8x | - | 20.1x | - | |||
| - | - | - | - | - | - | |||
This data is available for Pro users. Sign up to see all Aedes competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Aedes
| When was Aedes founded? | Aedes was founded in 1905. |
| Where is Aedes headquartered? | Aedes is headquartered in Italy. |
| How many employees does Aedes have? | As of today, Aedes has over 55 employees. |
| Is Aedes publicly listed? | Yes, Aedes is a public company listed on Borsa Italiana. |
| What is the stock symbol of Aedes? | Aedes trades under AEDES ticker. |
| When did Aedes go public? | Aedes went public in 1924. |
| Who are competitors of Aedes? | Aedes main competitors include Gafisa, Fastator, Tecnisa, TMM Real Estate, RomReal, Multihome, Aquaticus Real Estate, Torre Almirante FII, BBI Development, Joao Fortes Engenharia. |
| What is the current market cap of Aedes? | Aedes' current market cap is $12M. |
| What is the current revenue of Aedes? | Aedes' last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Aedes? | Current revenue multiple of Aedes is 14.1x. |
| Is Aedes profitable? | No, Aedes is not profitable. |
| How many companies Aedes has acquired to date? | Aedes hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Aedes has invested to date? | Aedes hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Aedes
Lists including Aedes
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




